For patients with positive lymph node metastasis, SLC39A2, SLC39A3, SLC39A7, SLC39A8, SLC39A12 and SLC39A13 high expression suggested a worse OS, but SLC39A10 high expression suggested a benefit OS. Here, SLC39A7 is linked to metastatic malignant neoplasm in the lymph nodes.